Literature DB >> 16404594

[Surgical procedures for severely obese patients: impact and long-term results].

N Potoczna1, R Steffen, F F Horber.   

Abstract

Obesity is a multifactorial, genetically-determined, neuroendocrine, and chronic condition. Conservative treatment of patients with class II and III obesity (BMI >35 kg/m(2)) has only modest long-term success. Surgical procedures have been used since 1954, and the methods used are continually being updated and improved. With experienced surgeons, patients can achieve a weight reduction from around 50% with purely restrictive procedures, increasing to 75% with combined restrictive-malabsorptive methods. All weight-loss methods offer a considerable improvement or elimination of obesity-related co-morbidities and substantially improvement of quality of life. Well-documented, long-term studies reveal a perioperative mortality of 0.2-1.0%, dependent on the surgeon's experience, and a maximum perioperative morbidity of 20%. Bariatric surgery is accepted as evidence based, safe and effective treatment of obesity.

Entities:  

Mesh:

Year:  2006        PMID: 16404594     DOI: 10.1007/s00108-005-1557-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

Review 1.  Obesity is a surgical disease: overview of obesity and bariatric surgery.

Authors:  Paul E O'Brien; John B Dixon; Wendy Brown
Journal:  ANZ J Surg       Date:  2004-04       Impact factor: 1.872

2.  Use and costs of bariatric surgery and prescription weight-loss medications.

Authors:  William E Encinosa; Didem M Bernard; Claudia A Steiner; Chi-Chang Chen
Journal:  Health Aff (Millwood)       Date:  2005 Jul-Aug       Impact factor: 6.301

3.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

4.  Impact of age, sex and body mass index on outcomes at four years after gastric banding.

Authors:  Ruth Branson; Natascha Potoczna; Ricarda Brunotte; Grazyna Piec; Thomas Ricklin; Rudolf Steffen; Fritz F Horber
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

5.  Long-term weight-loss maintenance: a meta-analysis of US studies.

Authors:  J W Anderson; E C Konz; R C Frederich; C L Wood
Journal:  Am J Clin Nutr       Date:  2001-11       Impact factor: 7.045

6.  Height, weight and mortality. The Norwegian experience.

Authors:  H T Waaler
Journal:  Acta Med Scand Suppl       Date:  1984

7.  Meta-analysis: surgical treatment of obesity.

Authors:  Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

8.  Meta-analysis: pharmacologic treatment of obesity.

Authors:  Zhaoping Li; Margaret Maglione; Wenli Tu; Walter Mojica; David Arterburn; Lisa R Shugarman; Lara Hilton; Marika Suttorp; Vanessa Solomon; Paul G Shekelle; Sally C Morton
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

9.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

10.  Obesity in general elective surgery.

Authors:  Daniel Dindo; Markus K Muller; Markus Weber; Pierre-Alain Clavien
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

View more
  2 in total

Review 1.  [Current concepts and trends in post-bariatric plastic surgery].

Authors:  O Scheufler; D Erdmann
Journal:  Chirurg       Date:  2007-04       Impact factor: 0.955

2.  The MC4R(I251L) allele is associated with better metabolic status and more weight loss after gastric bypass surgery.

Authors:  Uyenlinh L Mirshahi; Christopher D Still; Kathryn K Masker; Glenn S Gerhard; David J Carey; Tooraj Mirshahi
Journal:  J Clin Endocrinol Metab       Date:  2011-10-05       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.